We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGI
626
Somnigroup International
SGI
$15.1B
| $13.6M | 0.03% |
+395,484
| New | +$11.9M |
|
627
Intellia Therapeutics
NTLA
$1.5B
| $13.6M | 0.03% |
389,074
+381,674
| +5,158% | +$18.1M |
|
|
PICC
628
DELISTED
Pivotal Investment Corporation III
PICC
| $13.6M | 0.03% |
1,340,803
| – | – |
|
|
FSRX
629
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $13.6M | 0.03% |
1,349,630
| – | – |
|
|
CIIG
630
DELISTED
CIIG Capital Partners II, Inc. Class A Common Stock
CIIG
| $13.5M | 0.03% |
1,328,101
-7,471
| -0.6% | -$75.1K |
|
631
Waters Corp
WAT
$36.8B
| $13.5M | 0.03% |
39,416
-10,432
| -21% | -$3.3M |
|
632
CALL
Adobe
ADBE
$89.5B
| $13.5M | 0.03% |
40,100
+16,400
| +69% | +$5.25M |
|
633
CarMax
KMX
$8.27B
| $13.5M | 0.03% |
+221,306
| New | +$14.2M |
|
|
LVRA
634
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
| $13.5M | 0.03% |
1,334,992
| – | – |
|
635
Robinhood
HOOD
$85.2B
| $13.5M | 0.03% |
1,653,832
+720,725
| +77% | +$7.07M |
|
636
PUT
Visa
V
$677B
| $13.4M | 0.03% |
64,600
+23,200
| +56% | +$4.68M |
|
637
Walt Disney
DIS
$165B
| $13.4M | 0.03% |
154,234
-84,714
| -35% | -$8.1M |
|
|
AILE
638
DELISTED
iLearningEngines, Inc. Common Stock
AILE
| $13.3M | 0.03% |
1,327,014
| – | – |
|
639
AEON Biopharma
AEON
$11.1M
| $13.3M | 0.03% |
18,418
| – | – |
|
640
Trupanion
TRUP
$1.05B
| $13.3M | 0.03% |
280,365
+160,026
| +133% | +$8.33M |
|
|
BACA
641
DELISTED
Berenson Acquisition Corp. I
BACA
| $13.3M | 0.03% |
1,326,835
| – | – |
|
642
iShares National Muni Bond ETF
MUB
$45.1B
| $13.3M | 0.03% |
126,160
+123,400
| +4,471% | +$12.9M |
|
643
Griffon
GFF
$4.16B
| $13.2M | 0.03% |
369,702
+240,137
| +185% | +$8.01M |
|
|
CFLT
644
DELISTED
Confluent
CFLT
| $13.2M | 0.03% |
+593,020
| New | +$13.7M |
|
645
NRG Energy
NRG
$29.8B
| $13.2M | 0.03% |
+414,446
| New | +$16.4M |
|
646
Texas Roadhouse
TXRH
$12.7B
| $13.2M | 0.03% |
+144,857
| New | +$13.9M |
|
647
LCI Industries
LCII
$2.51B
| $13.2M | 0.03% |
142,451
+42,518
| +43% | +$4.17M |
|
648
Cameco
CCJ
$38.3B
| $13.2M | 0.03% |
580,877
-352,067
| -38% | -$8.28M |
|
649
Ashland
ASH
$3.04B
| $13.2M | 0.03% |
+122,422
| New | +$12.9M |
|
650
Avis
CAR
$5.63B
| $13.2M | 0.03% |
80,257
+17,789
| +28% | +$3.57M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.